KALA BIO, Inc.
KALA
Rangering i aksjer
#30843
Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the... Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanoparticle technology, specifically mucus penetrating particles (MPPs). Initially, their focus for these treatments is directed towards ophthalmic diseases. The company was established in 2009 by co-founders Justin Hanes, Robert S. Langer, and Colin R. Gardner, and its headquarters are located in Arlington, Massachusetts.
Aksjekurs
$0.75
Sist synkronisert: 2026-07-31
Markedsverdi
$14.50M
Endring (1 dag)
2.78%
Endring (1 år)
-98.42%
Land
US
Handel KALA BIO, Inc. (KALA)
Kategori
Healthcare
Historikk for aksjesplitt for KALA BIO, Inc. (KALA)
Aksjen KALA BIO, Inc. (symbol: KALA) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én KALA-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 KALA-aksjer.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én KALA-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 KALA-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
